Multi‐marker algorithms based on CXCL13, IL‐10, sIL‐2 receptor, and β2‐microglobulin in cerebrospinal fluid to diagnose CNS lymphoma

Multi‐marker algorithms based on CXCL13, IL‐10, sIL‐2 receptor, and β2‐microglobulin in cerebrospinal fluid to diagnose CNS lymphoma

Abstract Tumor biopsy is essential for the definitive diagnosis of central nervous system (CNS) lymphoma. However, the biopsy procedure carries the risk of complications such as bleeding, convulsions, and infection. Cerebrospinal fluid (CSF) β2‐microglobulin (β2‐MG), soluble IL‐2 receptor (sIL‐2R),...

Full description

Bibliographic Details
Main Authors: Masahiro Maeyama, Takashi Sasayama, Kazuhiro Tanaka, Satoshi Nakamizo, Hirotomo Tanaka, Masamitsu Nishihara, Yuichi Fujita, Kenji Sekiguchi, Masaaki Kohta, Katsu Mizukawa, Takanori Hirose, Tomoo Itoh, Eiji Kohmura
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Cancer Medicine
Subjects:
biomarker
central nervous system lymphoma
cerebrospinal fluid
CXCL13
IL‐10
Online Access:https://doi.org/10.1002/cam4.3048

Internet

https://doi.org/10.1002/cam4.3048

Similar Items